Literature DB >> 27009170

Lung exposure to lipopolysaccharide causes atherosclerotic plaque destabilisation.

Jen Erh Jaw1, Masashi Tsuruta2, Yeni Oh3, John Schipilow4, Yuki Hirano2, David A Ngan3, Koichi Suda5, Yuexin Li3, Jin Young Oh6, Konosuke Moritani2, Sheena Tam3, Nancy Ford4, Stephan van Eeden1, Joanne L Wright7, S F Paul Man1, Don D Sin8.   

Abstract

Epidemiological studies have implicated lung inflammation as a risk factor for acute cardiovascular events, but the underlying mechanisms linking lung injury with cardiovascular events are largely unknown.Our objective was to develop a novel murine model of acute atheromatous plaque rupture related to lung inflammation and to investigate the role of neutrophils in this process.Lipopolysaccharide (LPS; 3 mg·kg(-1)) or saline (control) was instilled directly into the lungs of male apolipoprotein E-null C57BL/6J mice following 8 weeks of a Western-type diet. 24 h later, atheromas in the right brachiocephalic trunk were assessed for stability ex vivo using high-resolution optical projection tomography and histology. 68% of LPS-exposed mice developed vulnerable plaques, characterised by intraplaque haemorrhage and thrombus, versus 12% of saline-exposed mice (p=0.0004). Plaque instability was detectable as early as 8 h post-intratracheal LPS instillation, but not with intraperitoneal instillation. Depletion of circulating neutrophils attenuated plaque rupture.We have established a novel plaque rupture model related to lung injury induced by intratracheal exposure to LPS. In this model, neutrophils play an important role in both lung inflammation and plaque rupture. This model could be useful for screening therapeutic targets to prevent acute vascular events related to lung inflammation.
Copyright ©ERS 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27009170     DOI: 10.1183/13993003.00972-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

Review 1.  Beyond gut feelings: how the gut microbiota regulates blood pressure.

Authors:  Francine Z Marques; Charles R Mackay; David M Kaye
Journal:  Nat Rev Cardiol       Date:  2017-08-24       Impact factor: 32.419

Review 2.  Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

Authors:  Monika Gawałko; Thomas A Agbaedeng; Arnela Saljic; Dominik N Müller; Nicola Wilck; Renate Schnabel; John Penders; Michiel Rienstra; Isabelle van Gelder; Thomas Jespersen; Ulrich Schotten; Harry J G M Crijns; Jonathan M Kalman; Prashanthan Sanders; Stanley Nattel; Dobromir Dobrev; Dominik Linz
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

Review 3.  Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.

Authors:  Francesco Violi; Vittoria Cammisotto; Simona Bartimoccia; Pasquale Pignatelli; Roberto Carnevale; Cristina Nocella
Journal:  Nat Rev Cardiol       Date:  2022-07-15       Impact factor: 49.421

4.  Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.

Authors:  Resat Cinar; Malliga R Iyer; George Kunos
Journal:  Br J Pharmacol       Date:  2021-04-17       Impact factor: 9.473

5.  Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.

Authors:  Daniele Pastori; Roberto Carnevale; Cristina Nocella; Marta Novo; Maria Santulli; Vittoria Cammisotto; Danilo Menichelli; Pasquale Pignatelli; Francesco Violi
Journal:  J Am Heart Assoc       Date:  2017-06-05       Impact factor: 5.501

Review 6.  Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia.

Authors:  Pirkko J Pussinen; Elisa Kopra; Milla Pietiäinen; Markku Lehto; Svetislav Zaric; Susanna Paju; Aino Salminen
Journal:  Periodontol 2000       Date:  2022-03-04       Impact factor: 12.239

Review 7.  Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group.

Authors:  Mathias W Pletz; Andreas Vestergaard Jensen; Christina Bahrs; Claudia Davenport; Jan Rupp; Martin Witzenrath; Grit Barten-Neiner; Martin Kolditz; Sabine Dettmer; James D Chalmers; Daiana Stolz; Norbert Suttorp; Stefano Aliberti; Wolfgang M Kuebler; Gernot Rohde
Journal:  Respir Res       Date:  2022-09-10

8.  Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque.

Authors:  Roberto Carnevale; Cristina Nocella; Vincenzo Petrozza; Vittoria Cammisotto; Luca Pacini; Veronica Sorrentino; Ombretta Martinelli; Luigi Irace; Sebastiano Sciarretta; Giacomo Frati; Daniele Pastori; Francesco Violi
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.